Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Joel Barrish
AddedMar 31, 2024
UpdatedMay 31, 2026
Joel Barrish

Joel Barrish

Board Member, Kojin Therapeutics

CrunchbaseLinkedIn

Joel Barrish's Career

Kojin Therapeutics
Kojin Therapeutics

Cambridge, MA, US

Board Member· Board
Jnana Therapeutics
Jnana Therapeutics

Boston, MA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Joel Barrish's Career

Kojin Therapeutics
Kojin Therapeutics
Series A$60M252020Cambridge, MA, US
Board Member· Board

Leadership at Kojin Therapeutics

Thomas CahillThomas CahillBoard Member
Vasanthi ViswanathanVasanthi ViswanathanCo-Founder
Gini DeshpandeGini DeshpandeBoard Member
Benjamin CravattBenjamin CravattCo-Founder
Amir NashatAmir NashatBoard Member
Luba GreenwoodLuba GreenwoodBoard Member

Similar to Kojin Therapeutics

Kymera TherapeuticsKymera TherapeuticsWatertown, MA, USDrugsest. 2017Kymera TherapeuticsWatertown, MA, US · est. 2017

Kymera Therapeutics, a global biopharmaceutical firm, innovates drugs for untreatable acute and chronic diseases.

Public · $879M167
Z SquaredZ SquaredWexford, PA, USPharmaceuticalsest. 1996Z SquaredWexford, PA, US · est. 1996

Coeptis Therapeutics: Developing and acquiring pharmaceutical products through strategic partnerships.

Public · $11M10
Kinaset TherapeuticsKinaset TherapeuticsMedfield, MA, USRespiratory Drugsest. 2020Kinaset TherapeuticsMedfield, MA, US · est. 2020

Kinaset Therapeutics develops novel respiratory drugs to address unmet medical needs.

Series A · $41.5M11
Jnana Therapeutics
Jnana Therapeutics
Series C$207M922016Boston, MA, US
Co-Founder

Leadership at Jnana Therapeutics

Brian CaliBrian CaliBoard Member
Matthew HammondMatthew HammondBoard Member
Donald NicholsonDonald NicholsonBoard Member
Stuart SchreiberStuart SchreiberBoard Member
Joanne KotzJoanne KotzCo-Founder
Carlo RizzutoCarlo RizzutoBoard Member

Joel Barrish's Similar Executives & Operators

WILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiJaeHong ChoiJaeHong ChoiBoard Member · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoMason YeoMason YeoBoard Member · KakaoBrian KimBrian KimCo-Founder · KakaoSean JohSean JohBoard Member · KakaoBrian KimBrian KimBoard Member · Kakao

People Similar to Joel Barrish

Cameron PittCameron PittCo-Founder · Quanta TherapeuticsJoshua SalafskyJoshua SalafskyCo-Founder · BlueLight TherapeuticsRichard MurrayRichard MurrayBoard Member · CaltechJohn M LeonardJohn M LeonardBoard Member · Intellia TherapeuticsDavid ThompsonDavid ThompsonCo-Founder · Azure Biotech